ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.440
+0.010 (0.70%)
May 2, 2025, 4:00 PM EDT - Market closed
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $142.82 million as of May 2, 2025. Its market cap has decreased by -65.11% in one year.
Market Cap
142.82M
Enterprise Value
335.04M
1-Year Change
-65.11%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $142.82M, a decrease of -93.01%. That is a compound annual growth rate of -41.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 142.82M | -25.78% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | 2.48B | 21.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.34B |
| Johnson & Johnson | 371.52B |
| UnitedHealth Group | 365.86B |
| AbbVie | 343.48B |
| Novo Nordisk | 293.18B |
| Abbott Laboratories | 227.83B |
| Novartis AG | 223.05B |
| AstraZeneca | 218.59B |